Nuzenio

First Patient Enrolled

First Patient Enrolled news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 10 latest news signals 10 publisher sources 100/100 entity strength

Latest news

UPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform - The Manila TimesThe Manila Times · Fri, 07 Aug 2026 16:24:32 GMTFirst Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 13:04:40 GMTPriovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS) - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 11:00:00 GMTObsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma - BioSpaceBioSpace · Thu, 06 Aug 2026 03:07:48 GMTAngioInsight™ Announces First Patient Enrolled in SMARTFLOW™ Clinical Study - Eagle-TribuneEagle-Tribune · Wed, 05 Aug 2026 12:00:07 GMTNurix Therapeutics Announces First Patient Enrolled in Phase 3 DAYBreak CLL-306 Study of Bexobrutideg in Relapsed/Refractory CLL/SLL - quiverquant.comquiverquant.com · Tue, 04 Aug 2026 05:10:00 GMTNurix Phase 3 Trial Tests Bexobrutideg Against CLL Standard of Care - Stock TitanStock Titan · Tue, 04 Aug 2026 05:03:02 GMTVDyne Announces First Patient Treated in TRIVITA US IDE Pivotal Study of the TriNova™ Transcatheter Tricuspid Valve Replacement System - Business WireBusiness Wire · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 16:24:32 GMTUPDATE - CurePSP Announces Enrollment of First Participant in the PSP Trial Platform - The Manila Times
Fri, 07 Aug 2026 13:04:40 GMTFirst Patient Enrolled in Registration-Enabling Amsoki-Cel Melanoma Cohort - Targeted Oncology
Thu, 06 Aug 2026 11:00:00 GMTPriovant Announces First Patients Enrolled in Phase 3 Study (BEACON+) of Brepocitinib in Cutaneous Sarcoidosis (CS) - GlobeNewswire
Thu, 06 Aug 2026 03:07:48 GMTObsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma - BioSpace
Wed, 05 Aug 2026 12:00:07 GMTAngioInsight™ Announces First Patient Enrolled in SMARTFLOW™ Clinical Study - Eagle-Tribune
Tue, 04 Aug 2026 05:10:00 GMTNurix Therapeutics Announces First Patient Enrolled in Phase 3 DAYBreak CLL-306 Study of Bexobrutideg in Relapsed/Refractory CLL/SLL - quiverquant.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for First Patient Enrolled.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

10 distinct publisher/source names are currently connected to this entity page.